Liposomal products market size is set to grow by USD 3,183.63 million from 2022-2027; The rising incidence of fungal disorders will boost the market- Technavio

NEW YORK, March 15, 2023 /PRNewswire/ -- The global liposomal products market size is estimated to grow by USD 3,183.63 million from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 9.65% during the forecast period. The growth of the market depends on several factors, including the increasing incidence of fungal disorders, the growing prevalence of cancer cases, and side effects associated with cancer treatment. However, late diagnosis and poor survival of patients with cancer may impede market growth during the forecast period. For more insights on the historic data (2017 to 2021) and forecast market size (2023 to 2027) - Request a sample report

Key factor driving market growth

• The rising incidence of fungal disorders is notably driving the liposomal drugs market growth. 
• Liposomal products work by either killing fungal cells or preventing the growth and reproduction of fungal cells. 
• The prevalence of fungal infection is growing due to a rise in the geriatric population, who are at high risk of fungal infections due to low immunity. 
• Furthermore, with the increase in chronic diseases, the number of immune-suppressed patients is rising, which increases the susceptibility to fungal infections. Additionally, most fungal infections can lead to chronic infections if not treated properly. 
• Therefore, the increase in the incidence of fungal infections such as Candida infections is a major factor driving the growth of the market.

What's New?

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
• Global competitiveness and key competitor positions 
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - buy the report!

Global Liposomal Products Market - Segmentation Assessment
Segment Overview
Technavio has segmented the market based on application (cancer, fungal infections, pain management, viral vaccines, and photodynamic therapy), and type (branded and generic).

• The market share growth of the cancer segment is estimated to be significant during the forecast period. Liposomal products are increasingly being used in cancer therapy. Advances in the development of liposomal vesicles have achieved both targeted drug delivery and controlled drug release. This property of liposomes is very useful in cancer therapy. Hence, increasing cancer diagnosis cases will drive the growth of the market during the forecast period. 

Geography Overview
By geography, the global liposomal products market is segmented into North America, Europe, Asia, and Rest of World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global liposomal products market.

• North America is estimated to contribute 36% to the growth of the global market during the forecast period. Cancer is one of the most common chronic diseases in the US. With the growing incidences of cancer, vendors are expected to invest in extensive research to develop effective drugs for the treatment of several cancers. Due to multiple side effects associated with anti-cancer drugs, the demand for liposomal products in this region is expected to increase during the forecast period. 

Insights on the market contribution of various segments including country and region wise, historic data (2017 to 2021) and forecast market size (2023 to 2027) - Download a Sample Report

Global Liposomal Products Market – Market Dynamic

Leading trends influencing the market 

• The rising adoption of quality by design (QbD) over traditional processes is the primary trend in the market. 
• The introduction of rational-based approaches such as QbD rather than empirical and simulation-based approaches has contributed to streamlined processes. It is expected to witness a high adoption rate during the forecast period.
• The adoption of QbD into the manufacturing process will likely contribute to quality, gradation, and consistency in the supply of excipients, leading to improved end products or pharmaceuticals. Hence, the growing adoption of QbD will further boost market growth during the forecast period. 

Major challenges hindering the market growth

• Late diagnosis and poor survival rate of patients with cancer is the major challenge impeding the market growth.
• According to the NHS, almost half of UK cancer patients are diagnosed at a later stage.
• When cancer reaches the terminal stage, it becomes difficult to treat with drug therapy, and leads to surgical treatments.
• Therefore, delayed diagnosis and poor survival rates associated with cancer limit the use of liposomal products and increase cancer-related mortality. Therefore, such factors may hinder the growth of the liposomal drugs market during the forecast period. 

Insights on Market Drivers, trends, & Challenges, historic period(2017 to 2021) and forecast period(2023 to 2027)- Request a sample report!

What are the key data covered in this Liposomal Products Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the liposomal products market between 2023 and 2027
• Precise estimation of the liposomal products market size and its contribution to the market in focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the liposomal products market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of liposomal products market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

• The disposable incontinence products market is estimated to grow at a CAGR of 4.6% between 2021 and 2026. The size of the market is forecast to increase by USD 3 billion. The growing prevalence of physical and medical conditions leading to urinary incontinence is notably driving the disposable incontinence products market growth, although factors such as fluctuating raw material prices may impede the market growth. 
• The microbial products market is projected to grow by USD 18.41 billion with a CAGR of 12.20% during the forecast period 2021 to 2026. The high demand for microbial products in the pharmaceutical industry is notably driving the microbial products market growth, although factors such as challenges related to manufacturing and formulation may impede the market growth.

Browse for Technavio Helth Care Market reports 

Table of Contents 

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global liposomal products market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on Global liposomal products market 2017 - 2021 ($ million)

• 4.2 Application Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)

• 4.3 Type Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)

• 6.2 Comparison by Application 
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application

• 6.3 Cancer - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)

• 6.4 Fungal infections - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Fungal infections - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Fungal infections - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Fungal infections - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Fungal infections - Year-over-year growth 2022-2027 (%)

• 6.5 Pain management - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Pain management - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Pain management - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Pain management - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Pain management - Year-over-year growth 2022-2027 (%)

• 6.6 Viral vaccines - Market size and forecast 2022-2027 
• Exhibit 46: Chart on Viral vaccines - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Viral vaccines - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Viral vaccines - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Viral vaccines - Year-over-year growth 2022-2027 (%)

• 6.7 Photodynamic therapy - Market size and forecast 2022-2027 
• Exhibit 50: Chart on Photodynamic therapy - Market size and forecast 2022-2027 ($ million)
• Exhibit 51: Data Table on Photodynamic therapy - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Chart on Photodynamic therapy - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Photodynamic therapy - Year-over-year growth 2022-2027 (%)

• 6.8 Market opportunity by Application 
• Exhibit 54: Market opportunity by Application ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 55: Chart on Type - Market share 2022-2027 (%)
• Exhibit 56: Data Table on Type - Market share 2022-2027 (%)

• 7.2 Comparison by Type
• Exhibit 57: Chart on Comparison by Type
• Exhibit 58: Data Table on Comparison by Type

• 7.3 Branded - Market size and forecast 2022-2027 
• Exhibit 59: Chart on Branded - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Branded - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Branded - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Branded - Year-over-year growth 2022-2027 (%)

• 7.4 Generic - Market size and forecast 2022-2027 
• Exhibit 63: Chart on Generic - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Generic - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Generic - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Generic - Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by Type 
• Exhibit 67: Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 69: Chart on Market share by geography 2022-2027 (%)
• Exhibit 70: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 71: Chart on Geographic comparison
• Exhibit 72: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027 
• Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 China - Market size and forecast 2022-2027 
• Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.10 France - Market size and forecast 2022-2027 
• Exhibit 101: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.11 Japan - Market size and forecast 2022-2027 
• Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 109: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 110: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 111: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 112: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 113: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 114: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 115: Matrix on vendor position and classification

• 12.3 Acthera Therapeutics AG 
• Exhibit 116: Acthera Therapeutics AG - Overview
• Exhibit 117: Acthera Therapeutics AG - Product / Service
• Exhibit 118: Acthera Therapeutics AG - Key offerings

• 12.4 Bausch Health Companies Inc. 
• Exhibit 119: Bausch Health Companies Inc. - Overview
• Exhibit 120: Bausch Health Companies Inc. - Business segments
• Exhibit 121: Bausch Health Companies Inc. - Key news
• Exhibit 122: Bausch Health Companies Inc. - Key offerings
• Exhibit 123: Bausch Health Companies Inc. - Segment focus

• 12.5 Baxter International Inc. 
• Exhibit 124: Baxter International Inc. - Overview
• Exhibit 125: Baxter International Inc. - Business segments
• Exhibit 126: Baxter International Inc. - Key news
• Exhibit 127: Baxter International Inc. - Key offerings
• Exhibit 128: Baxter International Inc. - Segment focus

• 12.6 Galen Ltd.
• Exhibit 129: Galen Ltd. - Overview
• Exhibit 130: Galen Ltd. - Product / Service
• Exhibit 131: Galen Ltd. - Key offerings

• 12.7 Gilead Sciences Inc.
• Exhibit 132: Gilead Sciences Inc. - Overview
• Exhibit 133: Gilead Sciences Inc. - Product / Service
• Exhibit 134: Gilead Sciences Inc. - Key news
• Exhibit 135: Gilead Sciences Inc. - Key offerings

• 12.8 Innocan Pharma Corp. Ltd. 
• Exhibit 136: Innocan Pharma Corp. Ltd. - Overview
• Exhibit 137: Innocan Pharma Corp. Ltd. - Product / Service
• Exhibit 138: Innocan Pharma Corp. Ltd. - Key offerings

• 12.9 Johnson and Johnson Services Inc. 
• Exhibit 139: Johnson and Johnson Services Inc. - Overview
• Exhibit 140: Johnson and Johnson Services Inc. - Business segments
• Exhibit 141: Johnson and Johnson Services Inc. - Key news
• Exhibit 142: Johnson and Johnson Services Inc. - Key offerings
• Exhibit 143: Johnson and Johnson Services Inc. - Segment focus

• 12.10 Leadiant Biosciences Inc. 
• Exhibit 144: Leadiant Biosciences Inc. - Overview
• Exhibit 145: Leadiant Biosciences Inc. - Product / Service
• Exhibit 146: Leadiant Biosciences Inc. - Key offerings

• 12.11 Liposoma B.V.
• Exhibit 147: Liposoma B.V. - Overview
• Exhibit 148: Liposoma B.V. - Product / Service
• Exhibit 149: Liposoma B.V. - Key offerings

• 12.12 Merrimack Pharmaceuticals Inc. 
• Exhibit 150: Merrimack Pharmaceuticals Inc. - Overview
• Exhibit 151: Merrimack Pharmaceuticals Inc. - Product / Service
• Exhibit 152: Merrimack Pharmaceuticals Inc. - Key offerings

• 12.13 Pacira BioSciences Inc. 
• Exhibit 153: Pacira BioSciences Inc. - Overview
• Exhibit 154: Pacira BioSciences Inc. - Business segments
• Exhibit 155: Pacira BioSciences Inc. - Key offerings
• Exhibit 156: Pacira BioSciences Inc. - Segment focus

• 12.14 Spectrum Pharmaceuticals Inc. 
• Exhibit 157: Spectrum Pharmaceuticals Inc. - Overview
• Exhibit 158: Spectrum Pharmaceuticals Inc. - Product / Service
• Exhibit 159: Spectrum Pharmaceuticals Inc. - Key offerings

• 12.15 Takeda Pharmaceutical Co. Ltd. 
• Exhibit 160: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 161: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 162: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 163: Takeda Pharmaceutical Co. Ltd. - Key offerings

• 12.16 The Lubrizol Corp.
• Exhibit 164: The Lubrizol Corp. - Overview
• Exhibit 165: The Lubrizol Corp. - Product / Service
• Exhibit 166: The Lubrizol Corp. - Key offerings

• 12.17 Viatris Inc.
• Exhibit 167: Viatris Inc. - Overview
• Exhibit 168: Viatris Inc. - Business segments
• Exhibit 169: Viatris Inc. - Key offerings
• Exhibit 170: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 171: Inclusions checklist
• Exhibit 172: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 173: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 174: Research methodology
• Exhibit 175: Validation techniques employed for market sizing
• Exhibit 176: Information sources

• 13.5 List of abbreviations 
• Exhibit 177: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio